Sherpa Ventures Fund, LP 4
Accession 0001140361-21-033143
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 5:35 PM ET
Size
25.4 KB
Accession
0001140361-21-033143
Insider Transaction Report
- Conversion
Common Stock
2021-09-28+4,926,417→ 5,120,448 total(indirect: See footnote.) - Conversion
Series B Preferred Stock
2021-09-28−3,076,224→ 0 total(indirect: See footnote.)→ Common Stock (3,076,224 underlying) - Conversion
Series B Preferred Stock
2021-09-28−3,834,088→ 0 total(indirect: See footnote.)→ Common Stock (3,834,088 underlying) - Conversion
Series C-1 Preferred Stock
2021-09-28−1,092,329→ 0 total(indirect: See footnote.)→ Common Stock (1,092,329 underlying) - Conversion
Series A Preferred Stock
2021-09-28−5,450,898→ 0 total(indirect: See footnote.)→ Common Stock (5,450,898 underlying) - Conversion
Series C-1 Preferred Stock
2021-09-28−1,092,329→ 0 total(indirect: See footnote.)→ Common Stock (1,092,329 underlying) - Conversion
Common Stock
2021-09-28+9,619,451→ 9,748,805 total(indirect: See footnote.) - Other
Common Stock
2021-09-28$12.80/sh+371,293$4,752,550→ 5,491,741 total(indirect: See footnote.)
- Conversion
Common Stock
2021-09-28+9,619,451→ 9,748,805 total(indirect: See footnote.) - Conversion
Series A Preferred Stock
2021-09-28−5,450,898→ 0 total(indirect: See footnote.)→ Common Stock (5,450,898 underlying) - Conversion
Series C-1 Preferred Stock
2021-09-28−1,092,329→ 0 total(indirect: See footnote.)→ Common Stock (1,092,329 underlying) - Conversion
Common Stock
2021-09-28+4,926,417→ 5,120,448 total(indirect: See footnote.) - Other
Common Stock
2021-09-28$12.80/sh+371,293$4,752,550→ 5,491,741 total(indirect: See footnote.) - Conversion
Series B Preferred Stock
2021-09-28−3,076,224→ 0 total(indirect: See footnote.)→ Common Stock (3,076,224 underlying) - Conversion
Series B Preferred Stock
2021-09-28−3,834,088→ 0 total(indirect: See footnote.)→ Common Stock (3,834,088 underlying) - Conversion
Series C-1 Preferred Stock
2021-09-28−1,092,329→ 0 total(indirect: See footnote.)→ Common Stock (1,092,329 underlying)
- Conversion
Series A Preferred Stock
2021-09-28−5,450,898→ 0 total(indirect: See footnote.)→ Common Stock (5,450,898 underlying) - Other
Common Stock
2021-09-28$12.80/sh+371,293$4,752,550→ 5,491,741 total(indirect: See footnote.) - Conversion
Common Stock
2021-09-28+9,619,451→ 9,748,805 total(indirect: See footnote.) - Conversion
Series B Preferred Stock
2021-09-28−3,076,224→ 0 total(indirect: See footnote.)→ Common Stock (3,076,224 underlying) - Conversion
Common Stock
2021-09-28+4,926,417→ 5,120,448 total(indirect: See footnote.) - Conversion
Series C-1 Preferred Stock
2021-09-28−1,092,329→ 0 total(indirect: See footnote.)→ Common Stock (1,092,329 underlying) - Conversion
Series B Preferred Stock
2021-09-28−3,834,088→ 0 total(indirect: See footnote.)→ Common Stock (3,834,088 underlying) - Conversion
Series C-1 Preferred Stock
2021-09-28−1,092,329→ 0 total(indirect: See footnote.)→ Common Stock (1,092,329 underlying)
- Other
Common Stock
2021-09-28$12.80/sh+371,293$4,752,550→ 5,491,741 total(indirect: See footnote.) - Conversion
Series A Preferred Stock
2021-09-28−5,450,898→ 0 total(indirect: See footnote.)→ Common Stock (5,450,898 underlying) - Conversion
Series B Preferred Stock
2021-09-28−3,834,088→ 0 total(indirect: See footnote.)→ Common Stock (3,834,088 underlying) - Conversion
Series B Preferred Stock
2021-09-28−3,076,224→ 0 total(indirect: See footnote.)→ Common Stock (3,076,224 underlying) - Conversion
Series C-1 Preferred Stock
2021-09-28−1,092,329→ 0 total(indirect: See footnote.)→ Common Stock (1,092,329 underlying) - Conversion
Common Stock
2021-09-28+9,619,451→ 9,748,805 total(indirect: See footnote.) - Conversion
Common Stock
2021-09-28+4,926,417→ 5,120,448 total(indirect: See footnote.) - Conversion
Series C-1 Preferred Stock
2021-09-28−1,092,329→ 0 total(indirect: See footnote.)→ Common Stock (1,092,329 underlying)
Footnotes (6)
- [F1]On September 28, 2021, the Series A Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F3]On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F4]The shares are held directly by Sherpa Ventures Fund, LP ("ACME I"). Sherpa Ventures Fund GP, LLC ("ACME GP I") is the general partner of ACME I. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein.
- [F5]The shares are held directly by Sherpa Ventures Fund II, LP ("ACME II"). Sherpa Ventures Fund II GP, LLC ("ACME GP II") is the general partner of ACME II. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein.
- [F6]On September 28, 2021, outstanding principal and accrued interest underlying a convertible note automatically converted into Common Stock upon the closing of the initial public offering of the Issuer's common stock at a conversion price equal to 80% of the initial public offering price per share.
Documents
Issuer
Cue Health Inc.
CIK 0001628945
Related Parties
1- filerCIK 0001580437
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 5:35 PM ET
- Size
- 25.4 KB